Yttrium-90
Jump to navigation
Jump to search
Indications
- Yttrium-90 (90-Y) ibritumomab tiuxetan (Zevalin) is used for hepatocellular carcinoma[2]
Pharmacokinetics
- decay product of strontium-90
- 1/2 life: 2.67 days[2]
- decay with emission of beta- particles to zirconium-90 (stable)
More general terms
References
- ↑ Wikipedia: Yttrium-90 http://en.wikipedia.org/wiki/Yttrium-90
- ↑ 2.0 2.1 2.2 PubChem: 104760